{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:59:15Z","timestamp":1790870355827,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["MRG6080067"],"award-info":[{"award-number":["MRG6080067"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thailand Science Research and Innovation","award":["RTA6280011"],"award-info":[{"award-number":["RTA6280011"]}]},{"name":"Kasetsart Veterinary Development Funds, Thailand"},{"DOI":"10.13039\/100009950","name":"The New Southbound Policy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Featured Areas Research Center Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104697","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:26:14Z","timestamp":1576646774000},"page":"104697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus"],"prefix":"10.1016","volume":"174","author":[{"given":"Sirin","family":"Theerawatanasirikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih Jung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanthawan","family":"Phetcharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porntippa","family":"Lekcharoensuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104697_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jac\/dki481","article-title":"Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture","volume":"57","author":"Balzarini","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.104697_bib2","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.3390\/v7122963","article-title":"Potential broad spectrum inhibitors of the Coronavirus 3CLpro: a virtual screening and structure-based drug design study","volume":"7","author":"Berry","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104697_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","article-title":"The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase","volume":"14","author":"Cameron","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104697_bib4","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.antiviral.2019.104697_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.antiviral.2019.104697_bib6","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104697_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104697_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00018-005-5455-y","article-title":"The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus","volume":"63","author":"Dixit","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2019.104697_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV\u2013infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104697_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/jcm.33.3.684-689.1995","article-title":"Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR","volume":"33","author":"Herrewegh","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104697_bib11","doi-asserted-by":"crossref","first-page":"31257","DOI":"10.1074\/jbc.M502577200","article-title":"Mechanism of the maturation process of SARS-CoV 3CL protease","volume":"280","author":"Hsu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104697_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2012.11.005","article-title":"Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease","volume":"97","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104697_bib13","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104697_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/cbic.201500040","article-title":"Genome mining of the hitachimycin biosynthetic gene cluster: involvement of a phenylalanine-2,3-aminomutase in biosynthesis","volume":"16","author":"Kudo","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.antiviral.2019.104697_bib15","first-page":"862","article-title":"Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate","volume":"318","author":"Kuo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104697_bib16","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2019.104697_bib51","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2011.12.109","article-title":"Cloned cDNA of A\/swine\/Iowa\/15\/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses","volume":"30","author":"Lekcharoensuk","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.104697_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104697_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11262-012-0864-0","article-title":"Full genome analysis of a novel type II feline coronavirus NTU156","volume":"46","author":"Lin","year":"2013","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2019.104697_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104697_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.antiviral.2019.104697_bib21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/np070145k","article-title":"Stictic acid derivatives from the lichen Usnea articulata and their antioxidant activities","volume":"70","author":"Loh\u00e9zic-Le D\u00e9v\u00e9hat","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.antiviral.2019.104697_bib22","first-page":"720","article-title":"Occurrence of feline coronavirus and feline infectious peritonitis virus in Thailand","volume":"43","author":"Manasateinkij","year":"2009","journal-title":"Kasetsart J.\/Nat. Sci."},{"key":"10.1016\/j.antiviral.2019.104697_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/09168451.2015.1132155","article-title":"Identification of the fluvirucin B2(Sch 38518) biosynthetic gene cluster from actinomadura fulva sub sp. Indica ATCC 53714: substrate Specificity of the \u03b2-amino acid selective adenylating enzyme FlvN","volume":"80","author":"Miyanaga","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.antiviral.2019.104697_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7164\/antibiotics.44.733","article-title":"Fluvirucins A1, A2, B1, B2, B3, B4 and B5, new antibiotics active against influenza a virus. I. production, isolation, chemical properties, and biological activities","volume":"44","author":"Naruse","year":"1991","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.104697_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7164\/antibiotics.44.756","article-title":"Fluvirucins A1, A2, B1, B2, B3, B4 and B5, new antibiotics active against influenza a virus. III. The stereochemistry and absolute configuration of fluvirucin A1","volume":"44","author":"Naruse","year":"1991","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.104697_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/jm960759e","article-title":"Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching","volume":"40","author":"Neamati","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104697_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1080\/07391102.2016.1188417","article-title":"An integrated approach of network-based systems biology, molecular docking, and molecular dynamics approach to unravel the role of existing antiviral molecules against AIDS-associated cancer","volume":"35","author":"Omer","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.antiviral.2019.104697_bib28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104697_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/12050997","article-title":"\u03b2-Orcinol metabolites from the lichen Hypotrachyna revoluta","author":"Papadopoulou","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2019.104697_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tvjl.2014.04.017","article-title":"An update on feline infectious peritonitis: virology and immunopathogenesis","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.antiviral.2019.104697_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An update on feline infectious peritonitis: diagnostics and therapeutics","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.antiviral.2019.104697_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A review of feline infectious peritonitis virus infection: 1963-2008","volume":"11","author":"Pedersen","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.antiviral.2019.104697_bib33","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104697_bib52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2019.104697_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1087057106296688","article-title":"Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library","volume":"12","author":"Severson","year":"2007","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2019.104697_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0960-894X(02)01057-0","article-title":"Four novel bis-(naphtho-\u03b3-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase","volume":"13","author":"Singh","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2019.104697_bib36","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.bmcl.2015.10.023","article-title":"X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: structural implications for drug design","volume":"25","author":"St John","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2019.104697_bib37","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1016\/j.bmcl.2011.07.016","article-title":"Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease","volume":"21","author":"Tiew","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2019.104697_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2019.104697_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7164\/antibiotics.34.259","article-title":"A new antitumor antibiotic, stubomycin","volume":"34","author":"Umezawa","year":"1981","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.104697_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ja.2011.106","article-title":"New isochaetochromin, an inhibitor of triacylglycerol synthesis in mammalian cells, produced by Penicillium sp. FKI-4942: II. structure elucidation","volume":"65","author":"Ugaki","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.104697_bib42","first-page":"1","article-title":"Harnessing macrophages for controlled-release drug delivery: lessons from microbes","volume":"9","author":"Visser","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104697_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0120405","article-title":"Depsides: lichen metabolites active against hepatitis C virus","volume":"10","author":"Vu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104697_bib44","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/JVI.02685-15","article-title":"Crystal structure of feline infectious peritonitis virus main protease in complex with synergetic dual inhibitors","volume":"90","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104697_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2361","article-title":"Computational identification of a transiently open L1\/S3 pocket for reactivation of mutant p53","volume":"4","author":"Wassman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.104697_bib46","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.3390\/molecules190914496","article-title":"Antioxidant activity and mechanisms of action of natural compounds isolated from lichens: a systematic review","volume":"19","author":"White","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2019.104697_bib47","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1073\/pnas.0403596101","article-title":"Small molecules targeting severe acute respiratory syndrome human coronavirus","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104697_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:17Z","timestamp":1759062677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219305601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"alternative-id":["S0166354219305601"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104697","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104697"}}